Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors

NCT02171663 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim